复发性流产女性后续妊娠围产期不良结局风险是否更高?

2025-02-07 生殖医学论坛 生殖医学论坛 发表于陕西省

复发性流产(RPL)的妇女后续妊娠围产期不良结局风险是否更高?

Study question

研究问题

Are women with recurrent pregnancy loss (RPL) at higher risk of adverse perinatal outcomes in a subsequent pregnancy?

复发性流产(RPL)的妇女后续妊娠围产期不良结局风险是否更高?

Summary answer

答案摘要

Women with a history of RPL have significant higher odds of adverse perinatal outcomes in a subsequent pregnancy.

有复发性妊娠流产史的妇女在再次妊娠时出现不良围产期结果的几率明显较高。

What is known already

已知信息

Studies have suggested that RPL women may have higher risks for obstetrical and perinatal complications such as hypertensive disorders, placental abruption, placenta accreta spectrum disorders, preterm delivery, and perinatal death in a subsequent pregnancy compared to those without an RPL history. However, the existing body of research presents a conflicting narrative, thus highlighting the need for a comprehensive understanding of the implications of RPL on pregnancy outcomes.

研究表明,与无RPL病史的妇女相比,RPL妇女在后续妊娠中发生产科和围产期并发症的风险较高,如高血压疾病、胎盘早剥、胎盘植入性疾病、早产和围产期死亡等。然而,现有的研究结论相互矛盾,因此强调需要全面了解 RPL对妊娠结局的影响。

Study design, size, duration

研究设计、规模和持续时间

A systematic review and meta-analysis was conducted. MEDLINE, EMBASE, Google Scholar and Cochrane databases were searched from inception until July 2023 for studies on RPL and adverse perinatal outcomes. Data was extracted by two independent reviewers.

进行了系统回顾和meta分析。在 MEDLINE、EMBASE、Google Scholar 和 Cochrane 数据库中检索了从开始到 2023 年 7 月期间有关 RPL 和不良围产期结局的研究。数据由两名独立审稿人提取。

Participants/materials, setting, methods

参与者/材料、环境、方法

DerSimonian and Laird random effect meta-analyses were performed to pool effect estimates. Results were presented as odd ratios with their respective 95% confidence intervals. Subgroup analyses were conducted for those with unexplained RPL and by number of pregnancy losses. Sensitivity analysis using only high-quality studies and influence analysis were performed. The Newcastle-Ottawa Scale was used to assess for risk of bias.

进行了 DerSimonian 和 Laird 随机效应meta分析,以集合效应评价。结果以比值比及其各自的 95% 可信区间表示。对原因不明的 RPL 以及流产次数进行了亚组分析。仅使用高质量研究进行灵敏度分析,并进行了影响因素分析。采用Newcastle-Ottawa表用于评估偏倚风险。

Main results and the role of chance

主要结果和偶然性的作用

The systematic search yielded 8,915 records, of which 42 studies (n = 5,619,124) were included in our meta-analysis. Women with RPL had higher odds of pre-eclampsia (OR 1.19; 95% CI, 1.03-1.37), pregnancy-induced hypertension (OR 1.24; 95% CI, 1.03-1.48), gestational diabetes (OR 1.76; 95% CI, 1.28-2.44), cesarean delivery (OR 1.65, 95% CI, 1.47-1.85), placental abruption (OR 1.57; 95% CI, 1.37-1.81), placenta previa (OR 1.93; 95% CI, 1.59-2.35; 7 studies), placenta accreta (OR 4.42; 95% CI, 3.09-6.33), preterm birth (OR 1.79; 95% CI, 1.65-1.93), very preterm birth (OR 2.58; 95% CI, 2.08-3.18), small for gestational age (OR 1.31; 95% CI, 1.15-1.78), congenital anomalies (OR 1.25; 95% CI, 1.02-1.53), stillbirth (OR 1.25; 95% CI, 1.04-1.51) and perinatal death (OR 2.04; 95% CI, 1.58-2.71) compared to women without a history of RPL. There was no association with aneuploidy.

系统搜索共获得 8,915 条记录,其中 42 项研究(n =5,619,124)被纳入我们的meta分析。与无PRL患者相比,患有 RPL 的妇女患先兆子痫(OR 1.19;95% CI,1.03-1.37)、妊娠高血压(OR 1.24; 95% CI, 1.03-1.48)、妊娠糖尿病(OR 1.76;95% CI,1.28-2.44)、剖宫产(OR1.65,95% CI,1.47-1.85),胎盘早剥(OR 1.57;95% CI,1.37-1.81)、前置胎盘(OR 1.93;95% CI,1.59-2.35;7 项研究)、胎盘植入(OR 4.42; 95% CI, 3.09-6.33), 早产 (OR 1.79; 95% CI, 1.65-1.93)、极早产(OR 2.58;95% CI,2.08-3.18)、小于孕龄儿(OR 1.31; 95% CI, 1.15-1.78), 先天性畸形 (OR 1.25; 95% CI, 1.02-1.53)、死产(OR 1.25;95% CI,1.04-1.51)和围产期死亡(OR 2.04;95%CI,1.58-2.71)几率更高。与非整倍体无关。

Limitations, reasons for caution

局限性,需谨慎的原因

Significant inter-study heterogeneity and inconsistent adjustment for confounders was noted across included studies.

研究间存在显著异质性,对混杂因素的调整不一致。

Wider implications of the findings

研究结果的广泛影响

RPL patients are at higher odds of adverse perinatal outcomes in a subsequent pregnancy, and therefore require additional counselling and monitoring in said pregnancy. There is an urgent need for further prospective research clarifying the relationship between RPL and perinatal outcomes.

RPL患者在后续妊娠中出现不良围产期结果的几率更高,因此,在怀孕期间需要额外的咨询和监测。迫切需要进一步的前瞻性研究,阐明 RPL 与围产期结局之间的关系。

参考文献:

I Letourneau, K Zitour, J Candeliere, M Hick, C  Q Wu, P-431 Perinatal outcomes after recurrent pregnancy loss: a systematic review and meta-analysis, Human Reproduction, Volume 39, Issue Supplement_1, July 2024, deae108.106, https://doi.org/10.1093/humrep/deae108.106

评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2250887, encodeId=7abf225088eab, content=<a href='/topic/show?id=3e8842545ee' target=_blank style='color:#2F92EE;'>#复发性流产#</a> <a href='/topic/show?id=5e87124019bf' target=_blank style='color:#2F92EE;'>#妊娠围产期不良结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42545, encryptionId=3e8842545ee, topicName=复发性流产), TopicDto(id=124019, encryptionId=5e87124019bf, topicName=妊娠围产期不良结局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Fri Feb 07 15:27:55 CST 2025, time=2025-02-07, status=1, ipAttribution=陕西省)]

相关资讯

专家访谈丨张建平教授:建立生殖免疫理论及诊疗体系,推进复发性流产、早产等疾病规范诊疗

该如何对生殖免疫相关疾病进行规范、科学的诊治管理?生殖免疫的未来发展方向如何?妇产科在线就上述问题特别采访到了大会主席、中山大学孙逸仙纪念医院张建平教授。

保胎成功率85%以上,环孢霉素A为什么有那么神奇吗?

1983年,CsA作为一种免疫抑制药物投入大规模临床应用中,开创了“器官移植的时代”。在使用过程中,有研究者发现,肾移植术后服用CsA的妇女大多能顺利产下健康胎儿,后代发育也没有受到明显的影响。

8个导致复发性流产的宫腔因素及处理方法,都是要点!

本文对常见的子宫功能和形态异常进行了分析,总结了其宫腔镜下的治疗方法,供大家参考。

低分子肝素在复发性流产中怎么用?用多少?都是细节!

本文对低分子肝素在复发性流产中的应用与监测部分内容进行了总结。

免疫因素与复发性流产的相关性分析!很详细!

维持免疫正常功能以及母胎界面免疫平衡是正常妊娠的关键,本文就母体免疫抗体和免疫细胞与RSA之间的关系进行综述。

中药联合阿司匹林治疗复发性流产的疗效及安全性分析!

鉴于当前现代医学针对RSA的治疗存在明显不足,故中药联合阿司匹林可能提高妊娠率、孕期激素水平、ACA转阴率,降低孕妇的高凝状态、降低易栓症的发生,从而减少胎儿发育不良具有一定的效果。

复发性流产的9大病因及对应治疗总结!

复发性流产是临床中常见的,治疗起来比较复杂的疾病,本文对复发性流产的定义、病因、筛查和治疗等内容进行了总结,供大家参考。

复发性流产(RSA)病因筛查及个体化用药

在育龄人群中发病率可达5%,近年来有明显上升趋势,且复发风险随流产次数的增加而上升。

复发性流产、不孕、胎儿宫内窘迫……你了解抗磷脂综合征吗

抗磷脂综合征(APS)是指由抗磷脂类抗体引起的一组临床征象的总称。临床上以动脉、静脉血栓形成、病态妊娠(妊娠早期流产和中晚期死胎)和血小板减少等症状为表现。

全文干货!复发性流产患者生殖道微生物群的研究进展

本文就生殖道微生物群与复发性流产的关系研究进行综述,以期为复发性流产的研究和临床治疗提供新的思路和参考。